Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 21,270 | 17,901 | 17,267 | 14,837 | 24,712 |
| Cost of Goods | 9,769 | 8,513 | 10,343 | 7,514 | 11,838 |
| Gross Profit | 11,501 | 9,388 | 6,924 | 7,322 | 12,874 |
| Operating Expenses | 11,807 | 13,595 | 14,086 | 11,107 | 10,839 |
| Operating Income | -306 | -4,207 | -7,162 | -3,785 | 2,036 |
| Interest Expense | 3,160 | 3,072 | 2,884 | 2,192 | 2,550 |
| Other Income | 2,222 | 14,899 | 3,459 | -7,194 | -12,494 |
| Pre-tax Income | -1,244 | 7,620 | -6,587 | -13,170 | -13,009 |
| Income Tax | -94 | -2,525 | 0 | -3,610 | 375 |
| Net Income Continuous | -1,150 | 10,145 | -6,587 | -9,560 | -13,383 |
| Net Income | $-1,150 | $10,145 | $-6,587 | $-9,560 | $-13,383 |
| EPS Basic Total Ops | -0.07 | 0.53 | -0.34 | -0.57 | -0.93 |
| EPS Basic Continuous Ops | -0.07 | 0.53 | -0.34 | -0.57 | -0.93 |
| EPS Diluted Total Ops | -0.07 | 0.52 | -0.34 | -0.57 | -0.93 |
| EPS Diluted Continuous Ops | -0.07 | 0.52 | -0.34 | -0.57 | -0.93 |
| EBITDA(a) | $3,416 | $12,241 | $-2,124 | $-9,655 | $-8,932 |